On the stock market since 1995, it operates in the world of health and science. It has 3,000 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Profit indicators sit around the sector average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
This grade is a blend: the profit side is strong, the sales tempo slow.
Clearly below the class average.
Price Momentum: The stock has lagged the market in recent months; investor interest is weak right now.
Financial Strength: The cash-and-debt balance is thin; the buffer for hard times is slim.
angles, checked one by one.
The 4 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
An investor who bought at the very peak is down 84% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
The company sells $593.8M a year; the problem isn’t sales — it’s costs running above that number.
There is $340.9M in the vault; even if every debt were paid off, $229.7M would remain.
Over the last 12 months, company executives reported 17 buys and 10 sells. Management buying with its own money is usually read as a good sign.
A loss of $55.8M against $593.8M in annual sales.
Buyers haven’t stepped back in yet; the price hasn’t found its footing. Report-card grade: 37/100. For a turnaround signal, the stock first needs to close the gap with the market.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 40/100.
On our five-subject report card, AZTA sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: AZTA has solid sales but closed last year at a loss. The road back to profit runs through spending discipline.